Patent details

EP3377534 Title: TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY

Basic Information

Publication number:
EP3377534
PCT Application Number:
US2016062884
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP168197184
PCT Publication Number:
WO2017087870
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY
French Title of Invention:
TRAITEMENT DU CANCER DU POUMON À L'AIDE D'UNE COMBINAISON D'UN ANTICORPS ANTI-PD-1 ET D'UN ANTICORPS ANTI-CTLA-4
German Title of Invention:
BEHANDLUNG VON LUNGENKREBS MIT EINER KOMBINATION AUS EINEM ANTI-PD-1-ANTIKÖRPER UND EINEM ANTI-CTLA-4-ANTIKÖRPER
SPC Number:

Dates

Filing date:
18/11/2016
Grant date:
18/06/2025
EP Publication Date:
26/09/2018
PCT Publication Date:
26/05/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/06/2025
EP B1 Publication Date:
18/06/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/11/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/06/2025
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
07/07/2025
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
FAITH, Nathan E.
Address:
United States (US)

Priority

1

Priority Number:
201562257139 P
Priority Date:
18/11/2015
Priority Country:
United States (US)

2

Priority Number:
201662345314 P
Priority Date:
03/06/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61K 39/00; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202525
Publication date:
18/06/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
24/06/2025 Power Of Attorney 1
07/07/2025 Outgoing Correspondence 1